← Open Payments lookup

JULIA MELVIN: Open Payments

NPI 1104087881 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,371 in 76 payments from 11 companies in 2025. Trend: 2023 $873 · 2024 $1,161 · 2025 $2,371

Food & beverage: $2,371
CompanyPaymentsAmount
Madrigal Pharmaceuticals24$1,007
Gilead Sciences, Inc.25$579
Ipsen Biopharmaceuticals, Inc10$319
Intercept Pharmaceuticals, Inc.4$183
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
AstraZeneca Pharmaceuticals LP2$69
ABBVIE INC.3$55
Novo Nordisk Inc1$20
Eton Pharmaceuticals, Inc.1$20
Boston Scientific Corporation1$19

Products named: REZDIFFRA, IQIRVO, OCALIVA, Vemlidy, XIFAXAN, MAVYRET, BEVESPI AEROSPHERE, Wegovy.

Industry payments across AZ — which companies pay providers there.